Citigroup’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
VF
HF
TRCT
AF
PUI
HI
Citigroup's VTAK Position: Q1 2026 in Review
Citigroup opened a new position in Catheter Precision (VTAK) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #5875 among its holdings. This is a return to the name: Citigroup previously reported a position in VTAK as recently as Q1 2022.
Citigroup first reported a position in VTAK in Q1 2022 and has held it in 2 quarters since. The position peaked at $21K in Q1 2022. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.
- Citigroup held 1 share of Catheter Precision worth $1 as of Q1 2026.
- Catheter Precision was a new Citigroup position in Q1 2026.
- Catheter Precision made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5875 holding.
- Citigroup first reported a position in Catheter Precision in Q1 2022 and has held it in 2 quarters since.
- Citigroup's Catheter Precision position peaked at $21K in Q1 2022.
- 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.